Article Details
Retrieved on: 2025-07-21 16:38:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Insilico Medicine's AI-generated candidate, Rentosertib, produced strong results recently in peer-reviewed phase 2a trials for use in improving ...
Article found on: pharmaceuticalmanufacturer.media
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here